Results Snapshot
Figures in Cr
Consolidate Nine Monthly Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
1,893.08
1,637.69
1,417.49
1,252.73
1,033.16
715.39
825.27
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,893.08
1,637.69
1,417.49
1,252.73
1,033.16
715.39
825.27
Raw Material Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Purchase of Finished goods
520.98
436.14
354.72
316.51
269.94
164.59
175.38
(Increase) / Decrease In Stocks
-5.39
-9.57
-2.03
-8.84
-6.06
2.53
3.74
Employee Cost
286.13
260.67
231.39
206.26
172.98
142.13
156.41
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
408.74
352.47
307.96
264.82
211.55
157.56
185.59
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
341.91
316.42
287.89
251.62
209.92
161.35
167.99
Total Expenditure (Excl Depreciation)
1,552.37
1,356.13
1,179.93
1,030.37
858.33
628.16
689.11
Operating Profit (PBDIT) excl Other Income
340.71
281.56
237.56
222.36
174.83
87.23
136.16
Other Income
11.92
24.58
11.89
8.53
9.66
12.55
5.28
Operating Profit (PBDIT)
352.63
306.14
249.45
230.89
184.49
99.78
141.44
Interest
133.87
110.39
81.90
77.87
73.63
93.26
101.85
Exceptional Items
-12.67
0.00
0.00
0.00
94.61
-8.75
0.00
Gross Profit (PBDT)
206.09
195.75
167.55
153.02
205.47
-2.23
39.59
Depreciation
181.36
153.27
128.38
121.27
117.18
120.84
106.39
Profit Before Tax
24.68
43.38
39.16
31.74
88.29
-123.07
-66.80
Tax
6.93
1.28
21.64
19.77
50.18
-16.97
-2.57
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
17.80
41.20
17.53
11.98
38.11
-106.10
-64.23
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
17.80
41.20
17.53
11.98
38.11
-106.10
-64.23
Share in Profit of Associates
0.94
0.86
0.33
-0.01
-1.44
-1.24
-10.78
Minority Interest
-4.09
-3.47
4.48
2.32
3.03
5.09
-0.80
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
11.59
37.05
26.88
20.97
47.74
-91.29
-63.11
Equity Capital
141.01
139.40
139.28
139.09
138.99
125.35
88.67
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Diluted Earnings per share
-0.68
0.49
0.41
0.54
-3.55
-2.33
-2.57
Operating Profit Margin (Excl OI)
18.0%
17.19%
16.76%
17.75%
16.92%
12.19%
16.5%
Gross Profit Margin
10.89%
11.95%
11.82%
12.21%
19.89%
-0.31%
4.8%
PAT Margin
0.94%
2.52%
1.24%
0.96%
3.69%
-14.83%
-7.78%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Nine Monthly Analysis Highlights
Net Sales
YoY Growth in nine months ended Dec 2025 is 15.59% vs 15.53% in Dec 2024
Consolidate Net Profit
YoY Growth in nine months ended Dec 2025 is -68.72% vs 37.83% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in nine months ended Dec 2025 is 21.01% vs 18.52% in Dec 2024
Interest
YoY Growth in nine months ended Dec 2025 is 21.27% vs 34.79% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in nine months ended Dec 2025 has improved from Dec 2024
Compare Nine Monthly Results Of Health.Global With
Figures in Cr
Consolidate Nine Monthly Results
Change(INR)
Change(%)
Net Sales
1,893.08
0
1,893.08
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,893.08
0
1,893.08
Raw Material Cost
0.00
0
0.00
Purchase of Finished goods
520.98
0
520.98
(Increase) / Decrease In Stocks
-5.39
0
-5.39
Employee Cost
286.13
0
286.13
Power Cost
0.00
0
0.00
Manufacturing Expenses
408.74
0
408.74
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
341.91
0.00
341.91
Total Expenditure (Excl Depreciation)
1,552.37
0
1,552.37
Operating Profit (PBDIT) excl Other Income
340.71
0.00
340.71
Other Income
11.92
0
11.92
Operating Profit (PBDIT)
352.63
0
352.63
Interest
133.87
0
133.87
Exceptional Items
-12.67
0
-12.67
Gross Profit (PBDT)
206.09
0
206.09
Depreciation
181.36
0
181.36
Profit Before Tax
24.68
0
24.68
Tax
6.93
0
6.93
Provisions and contingencies
0.00
0
0.00
Profit After Tax
17.80
0
17.80
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
17.80
0
17.80
Share in Profit of Associates
0.94
0
0.94
Minority Interest
-4.09
0
-4.09
Other related items
0.00
0.00
0.00
Consolidated Net Profit
11.59
0
11.59
Equity Capital
141.01
0
141.01
Face Value
10.00
0
0.00
Reserves
0.00
0
0.00
Gross Profit Margin
10.89%
0%
0.00
10.89%
PAT Margin
0.94%
0%
0.00
0.94%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Nine Monthly - Net Sales
Net Sales 1,893.08 Cr
in Dec 2025Figures in Cr
YoY Growth in nine months ended Dec 2025 is 15.59% vs 15.53% in Dec 2024
Nine Monthly - Consolidate Net Profit
Consolidate Net Profit 11.59 Cr
in Dec 2025Figures in Cr
YoY Growth in nine months ended Dec 2025 is -68.72% vs 37.83% in Dec 2024
Nine Monthly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 340.71 Cr
in Dec 2025Figures in Cr
YoY Growth in nine months ended Dec 2025 is 21.01% vs 18.52% in Dec 2024
Nine Monthly - Interest
Interest 133.87 Cr
in Dec 2025Figures in Cr
YoY Growth in nine months ended Dec 2025 is 21.27% vs 34.79% in Dec 2024
Nine Monthly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 18.00%
in Dec 2025Figures in %
YoY Growth in nine months ended Dec 2025 has improved from Dec 2024






